Here, to know whether there is difference in CD44+Fbs and CD44−Fbs on drug resistance in breast cancer cells, MCF‐7 and SKBR3 cells were exposed to paclitaxel, and then examined the cell survival rate of days 1, 3 and 5. Here, CD44 is linked to breast carcinoma.